CVS Health plans to split into two public companies by the first half of 2028, the company announced Wednesday. The plan would separate its roughly 9,000 retail pharmacies from its insurance business and its pharmacy benefit manager, Caremark. CVS said the decision follows a "comprehensive strategic review" by its board of directors.

The separation would reverse the company's $78 billion acquisition of Aetna in 2018. CVS shares fell roughly 11% on Wednesday, according to the report.

CVS CEO David Joyner told CNBC's "Squawk on the Street" that the split is "out of a position of strength." He pointed to recovery in Aetna's Medicare business and solid performance in retail pharmacy. The insurance and PBM company will keep the CVS Health name and be run by Joyner. The pharmacy company will be called CVS Pharmacy and led by Prem Shah, currently group president of CVS Health. CVS said additional leadership and board members will be announced later.

CVS also reported third-quarter results that topped Wall Street expectations. Total sales rose to $108.40 billion from $102.87 billion a year earlier. The company said its insurer and PBM will also include Oak Street Health, Signify Health and its specialty drug business.

Joyner said the two businesses' synergies "are going to be preserved in commercial agreements between the two organizations." Leerink Partners analyst Michael Cherny said the split reflects "the stability of the pharmacy," and noted that the rationale could extend to state legislative scrutiny of vertical integration. Republicans in Tennessee and Arkansas have passed laws that would ban co-ownership of PBMs and pharmacies. CVS and other companies have challenged those laws in court.